At a glance
- Originator Bristol-Myers Squibb
- Class Anxiolytics; Small molecules
- Mechanism of Action Corticotropin-releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 13 Sep 2000 New profile
- 13 Sep 2000 Preclinical development for Anxiety disorders in USA (Unknown route)